Heart failure is the enormous market indication- yes.
And clearly there is much greater value represented for the company as a whole and unique Sozo Bioimpedence technology and analyse.
Still all being progressed
The company is focused absolutely atm on capturing lymphedema market totally and cashflow and profits, and garnering the complete monopoly advantage and position which ImpediMed holds in the US and globally.
Ann: First Top 5 National Payor Covering SOZO Testing, page-30
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $153.7M | |||
| Open | High | Low | Value | Volume |
| 7.6¢ | 7.7¢ | 7.4¢ | $140.4K | 1.863M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 149896 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 136785 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.6¢ |
Change
0.000 ( 2.56 %) |
||||
| Open | High | Low | Volume | ||
| 7.5¢ | 7.8¢ | 7.4¢ | 410811 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| IPD (ASX) Chart |